# SCRT Based iTNT vs. LCRT Based TNT for MSS Locally Advanced Rectal Cancer

> **NCT07551479** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Fudan University** · enrollment: 612 (estimated)

## Conditions studied

- Locally Advanced Rectal Cancer (LARC)
- MSS (Microsatellite Stable)

## Interventions

- **RADIATION:** short-course radiaotherapy
- **RADIATION:** long-course chemoradiaothearpy
- **DRUG:** Capecitabine
- **DRUG:** Oxaliplatin
- **DRUG:** PD-1 inhibitor

## Key facts

- **NCT ID:** NCT07551479
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2032-12-31
- **Final completion:** 2035-12-31
- **Target enrollment:** 612 (ESTIMATED)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07551479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07551479, "SCRT Based iTNT vs. LCRT Based TNT for MSS Locally Advanced Rectal Cancer". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT07551479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*